Butterfly Medical announced that it completed the final 12-month follow-up for all patients in a study of its prostatic ...
The prospective, double-blind, randomized controlled trial (RCT) enrolled 244 patients to evaluate the Butterfly Prostatic Retraction Device, a minimally invasive, reversible implant that mechanically ...
Mount Sinai advances prostate care with AI-powered therapy designed to preserve continence and sexual function The Mount Sinai Hospital is ranked ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company is racing to advance ...
The FDA has approved the Vanquish Water Vapor Ablation System, which uses steam to destroy prostate tumors. However, the efficacy of the device in eliminating cancer has yet to be established, ...
Less than a week after making a regulatory submission for a $1 million capital raise, prostate health company ProUroCare Medical, based in Eden Prairie, Minnesota, announced that it has secured market ...
Discover the latest on medical devices with press releases highlighting innovations, trends, and regulatory updates shaping the healthcare industry. Stay informed on key developments in medical device ...
Profound Medical ( ($TSE:PRN) ) has shared an announcement. Profound Medical announced that The Johns Hopkins Hospital has performed its first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results